Skip to content

Application of SIDD risk score measurement on retrospective T2D individuals

Evaluation of risk score to identify the Severe Insulin Deficient Diabetes in the Type 2 Diabetes population - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/107602
Enrollment
5009
Registered
2026-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Madras Diabetes Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals with Type 2 Diabetes Mellitus Individuals with duration of diabetes less than 5 years Individuals with GAD antibody negative Availability of required clinical and laboratory parameters such as BMI, HbA1c, Fasting Glucose, eGFR

Exclusion criteria

Exclusion criteria: Individuals those who are not representative of any of the inclusion criteria

Design outcomes

Primary

MeasureTime frame
Identify the proportion of Type 2 diabetes (T2D) individuals with low, intermediate, or high risk for Severe Insulin Deficient Diabetes form of T2D subtypesTimepoint: Baseline

Secondary

MeasureTime frame
Comparison of HbA1c & fasting plasma glucose across T2D individuals with SIDD risk categories, including adjusted analyses for age, BMI, & diabetes duration. Evaluation of BMI-wise distribution, renal function (eGFR) differences, other diabetes complication assessment with the categories of Type 2 Diabetes SIDD risk individuals & overall applicability of SIDD risk estimation Timepoint: Baseline

Countries

India

Contacts

Public ContactBASKAR

Madras Diabetes Research Foundation

drmohans@diabetes.ind.in9840097370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026